AbbVie Inc.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals

Other Names/Subsidiaries

  • Aliada Therapeutics
  • Allergan
  • Celsius Therapeutics
  • Cerevel Therapeutics Holdings
  • DJS Antibodies
  • ImmunoGen
  • Luminera
  • Nimble Therapeutics
  • Mavupharma
  • Mitokinin
  • Pharmacyclics
  • Stemcentrx
  • Syndesi Therapeutics
See more in Biomedtracker

Latest on AbbVie Inc.

Scrip

Titans Of Pharma: Lilly’s Ricks Tops Big Pharma Pay Chart

 
• By Eleanor Malone, Edwin Elmhirst, and Kosh Naran

Riding high on the wave of its dual GIP/GLP-1 agonist, tirzepatide, Eli Lilly awarded its CEO the highest total remuneration package of the top 12 big pharma companies in 2024. David Ricks’s total com

Scrip

Genmab Looks To Keep Ahead Of Lilly In Folate ADCs

 
• By Andrew McConaghie

Genmab has been boosted by new data for its antibody-drug conjugate, rinatabart sesutecan (Rina-S), but is aiming to move fast to keep ahead of competitor Lilly. The latest Phase I/II trial results fr

Scrip

Vigil’s Iluzanebart Disappoints In Rare Neurodegenerative Disease

 
• By Jessica Merrill

Vigil Neuroscience’s TREM2 agonist iluzanebart failed in a Phase II study for the treatment of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and deadly neurod

Scrip

ASCO: Merck’s Zilo-V Shows Activity, But Numbers Still Small

 
• By Alaric DeArment

Merck & Co.’s initial Phase II/III waveLINE-003 data for zilovertamab vedotin (zilo-V) in diffuse large B-cell lymphoma (DLBCL) at the American Society of Clinical Oncology meeting in Chicago rais